“You’re going to need a bigger boat,” Steve Anderson, president and CEO of the National Association of Chain Drug Stores, told attendees of the NACDS Annual Meeting Business Program Sunday morning.
Walgreens is responding to a high number of whooping cough cases in Washington with vaccine offer.
HealthPrize Technologies and MeadWestvaco announced plans to collaborate to provide a program to pharmaceutical companies, pharmacy chains and the patients they serve.
The Arthritis Foundation on Monday realigned its strategic focus to better aligned with consumer advocacy.
The Consumer Pain Advocacy Task Force recently requested the Department of Health and Human Services to begin the budget process for its National Pain Strategy to speed implementation.
A new poll finds that while most healthcare executives support value-based reimbursement, few would abandon fee-for-service entirely.
Epic Pharma has added two new generic drugs to its portfolio of products.
Rite Aid on Monday announced it will transition its existing loyalty program to the new wellness+ with Plenti.
Amneal Pharmaceuticals and Actavis Australia on Friday announced that Amneal completed the acquisition of most of Actavis’ in-country generic pharmaceuticals business.
Camber Pharmaceuticals on Friday announced the launch of famciclovir tablets in 125-, 250- and 500-mg dosage strengths.